Related Experiment Videos
p53 Homologue p63 represses epidermal growth factor receptor expression
1Laboratory of Molecular Biology, CCR, NCI, National Institutes of Health, Bethesda, Maryland 20892-4255, USA.
The Journal of Biological Chemistry
|September 8, 2001
Summary
TAp63gamma, a p53 relative, surprisingly represses epidermal growth factor receptor (EGFR) expression by interfering with Sp1 transcription factor binding to the EGFR promoter, revealing a novel regulatory mechanism.
Area of Science:
- Molecular Biology
- Cancer Biology
- Gene Regulation
Background:
- Tumor suppressor p53 transactivates epidermal growth factor receptor (EGFR) expression.
- p63 gene products are p53 relatives with similar functions.
- The role of TAp63gamma in EGFR regulation was previously unknown.
Purpose of the Study:
- To investigate the function of TAp63gamma in regulating EGFR expression.
- To elucidate the mechanism by which TAp63gamma affects EGFR promoter activity.
Main Methods:
- Transient transfection assays to assess EGFR promoter activity.
- Electrophoretic mobility shift assays (EMSA) to study DNA-protein interactions.
- Immunoprecipitation to analyze protein interactions.
Main Results:
- TAp63gamma showed minimal binding to the EGFR promoter's p53-responsive element.
- TAp63gamma repressed basal EGFR promoter activity and endogenous EGFR expression.
- Repression was dependent on Sp1 binding sites in the EGFR promoter (-348 to -293).
- TAp63gamma directly interacted with Sp1, impairing Sp1 binding to DNA.
Conclusions:
- TAp63gamma negatively regulates EGFR gene expression.
- This regulation occurs through TAp63gamma's interaction with the transcription factor Sp1.
- TAp63gamma's interaction with basal transcription factors provides a novel mechanism for EGFR gene regulation.